2013/3 GaBI Journal Table of Contents

Published in: Volume 2 / Year 2013 / Issue 3
Category: 2013/3 GaBI Journal Table of Contents
Visits: 2721 total, 1 today

Contents

Editor’s Letter

Latest features in GaBI Journal, 2013, Issue 3

Editorial

Italy’s final position paper on biosimilars and new price and reimbursement pathway

Commentary

Commentary on the recommendations of the European Society for Organ Transplantation Advisory Committee on generic substitution of immunosuppressive drugs

Biosimilar monoclonal antibodies—challenges and opportunities in Europe

Ongoing initiatives in the Republic of Srpska to enhance prescribing efficiency; influence and future directions

Original Research

Efficient production of recombinant parathyroid hormone (rPTH) fragment 1-34 in the methylotrophic yeast Hansenula polymorpha

Regional tenders on biosimilars in Italy: potentially competitive?

Assessing biosimilarity using the method of generalized pivotal quantities

Review Article

Steps to ensure adequate supply of biological medicines: considerations for the healthcare provider

Safety and toxicity of biosimilars—EU versus US regulation

Perspective

Licensing and prescribing biosimilars in Australia

Regulatory

US state legislation on biosimilars substitution

Abstracted Scientific Content

Biosimilar monoclonal antibodies – time for a regulatory rethink

 

Go Back Print

Leave a Reply